Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
Go back to Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress| CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) | Delayed: 32.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.98 | 52 Week High | $18.62 | |||
| Open | $32.98 | 52 Week Low | $2.85 | |||
| Day High | $32.98 | P/E | N/A | |||
| Day Low | $32.98 | EPS | $-1.02 | |||
| Volume | 3,641 | |||||
